- Q4 2023 PDS Biotechnology Corp Earnings Call TranscriptMar 27, 2024$3.85 (-14.06%)Earnings
- Q3 2023 PDS Biotechnology Corp Earnings Call TranscriptNov 14, 2023$6.23 (+18.55%)Earnings
- PDS Biotechnology Corp To Host Key Opinion Leader Roundtable TranscriptOct 03, 2023
- PDS Biotechnology Corp at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- Q2 2023 PDS Biotechnology Corp Earnings Call TranscriptAug 14, 2023$5.33 (+9.90%)Earnings
- PDS Biotechnology Corp To Host Post ASCO Call TranscriptJun 06, 2023
- Q1 2023 PDS Biotechnology Corp Earnings Call TranscriptMay 15, 2023$6.93 (+7.44%)Earnings
- PDS Biotechnology Corp To Host Key Opinion Leader Call TranscriptApr 21, 2023
- Q4 2022 PDS Biotechnology Corp Earnings Call TranscriptMar 28, 2023$5.85 (+2.99%)Earnings
- PDS Biotechnology Corp at Noble Capital Markets Takeaway Series on Channelchek- J.P. Morgan Healthcare Conference TranscriptJan 26, 2023
- PDS Biotechnology Corp Announces Exclusive Global License Agreement for Investigational IL-12 Tumor-Targeted Cytokine TranscriptJan 03, 2023
- Q3 2022 PDS Biotechnology Corp Earnings Call TranscriptNov 14, 2022$7.06 (+26.07%)Earnings
- PDS Biotechnology Corp Head And Neck Cancer KOL Roundtable TranscriptOct 26, 2022
- PDS Biotechnology Corp Update Call TranscriptAug 25, 2022
- Q2 2022 PDS Biotechnology Corp Earnings Call TranscriptAug 08, 2022$5.19 (-2.26%)Earnings
- PDS Biotechnology Corp Post ASCO Call TranscriptJun 07, 2022
- Q1 2022 PDS Biotechnology Corp Earnings Call TranscriptMay 11, 2022$3.76 (-15.88%)Earnings
- Q4 2021 PDS Biotechnology Corp Earnings Call TranscriptMar 31, 2022$6.19 (-1.59%)Earnings
- PDS Biotechnology Corp Extraordinary Shareholders Meeting TranscriptJan 19, 2022
- Q3 2021 PDS Biotechnology Corp Earnings Call TranscriptNov 10, 2021$10.2 (-4.40%)Earnings
- Q2 2021 PDS Biotechnology Corp Earnings Call TranscriptAug 12, 2021$10.89 (+2.83%)Earnings
- PDS Biotechnology Corp Oncology R&D Day TranscriptJun 16, 2021
- PDS Biotechnology Post-ASCO Conference Call - Corporate Analyst Meeting TranscriptJun 08, 2021
- Q1 2021 PDS Biotechnology Corp Earnings Call TranscriptMay 13, 2021$4.48 (+1.82%)Earnings
- Q2 2020 PDS Biotechnology Corp Earnings Call TranscriptAug 13, 2020$2.94Earnings
PDS Biotechnology Corp To Host Post ASCO Call Transcript
Good morning, and welcome to PDS Biotechnology's post 2023 ASCO Conference Call and Webcast. With me today from the company are Dr. Frank Bedu-Addo, Chief Executive Officer; Dr. Lauren V. Wood, Chief Medical Officer; and Matt Hill, Chief Financial Officer.
Before we begin, we want to remind everyone that on today's call, the company will be making forward-looking statements regarding regulatory and product candidate development plans, as well as research activities. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted. A description of these risks can be found in PDS Biotech's most recent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this conference call. Except to the extent required by applicable law or regulation, PDSB undertakes no obligation to update the forward-looking statements included today to reflect subsequent events or circumstances.
With that, I would now like to turn the call over to Dr. Frank Bedu-Addo. Frank?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)